Antithrombotic treatment in the prevention of ischemic stroke

Approximately 5.7 million people died from stroke in 2005 [1]. According to World Health Organization estimates, figures are predicted to increase to 23 million first-ever strokes, 77 million stroke survivors, 61 million disability adjusted life years (DALYs) and 7.8 million deaths in the next 20 years [2]. Heart disease and stroke are leading causes of DALYs lost and deaths worldwide [3]. Over 70 % of ischemic strokes are first events, which makes primary prevention immensely important. The treatments for acute ischemic stroke have emerged during the last decade and there is growing evidence of efficacy and importance of secondary prevention. We foresee that patients at high risk of vascular events could reduce their risk by 75 to 80 % through optimal prevention strategies including a combination of lifestyle changes and medical therapy [4]. In this review, we will focus on the aspects of antithrombotic treatment of ischemic stroke (IS) in the primary and secondary prevention.

Yazar Emre, Ufuk
Rantanen, Kirsi
Tatlisumak, Turgut
Yayın Türü Review
Tek Biçim Adres https://hdl.handle.net/20.500.12628/2099
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
PubMed İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu
Sayfalar 817 - 823
Yayın Yılı 2007
Eser Adı
[dc.title]
Antithrombotic treatment in the prevention of ischemic stroke
Yayın Yılı
[dc.date.issued]
2007
Yayıncı
[dc.publisher]
BENTHAM SCIENCE PUBL LTD
Yayın Türü
[dc.type]
review
Açıklama
[dc.description]
WOS: 000248665300005
Açıklama
[dc.description]
PubMed: 17630934
Özet
[dc.description.abstract]
Approximately 5.7 million people died from stroke in 2005 [1]. According to World Health Organization estimates, figures are predicted to increase to 23 million first-ever strokes, 77 million stroke survivors, 61 million disability adjusted life years (DALYs) and 7.8 million deaths in the next 20 years [2]. Heart disease and stroke are leading causes of DALYs lost and deaths worldwide [3]. Over 70 % of ischemic strokes are first events, which makes primary prevention immensely important. The treatments for acute ischemic stroke have emerged during the last decade and there is growing evidence of efficacy and importance of secondary prevention. We foresee that patients at high risk of vascular events could reduce their risk by 75 to 80 % through optimal prevention strategies including a combination of lifestyle changes and medical therapy [4]. In this review, we will focus on the aspects of antithrombotic treatment of ischemic stroke (IS) in the primary and secondary prevention.
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/2099
Yayın Dili
[dc.language.iso]
eng
Yazar
[dc.contributor.author]
Emre, Ufuk
Yazar
[dc.contributor.author]
Rantanen, Kirsi
Yazar
[dc.contributor.author]
Tatlisumak, Turgut
Haklar
[dc.rights]
info:eu-repo/semantics/closedAccess
İlk Sayfa Sayısı
[dc.identifier.startpage]
817
Son Sayfa Sayısı
[dc.identifier.endpage]
823
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
10
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
07 Nisan 2024 06:15
Google Kontrol
Tıklayınız
million stroke prevention ischemic secondary deaths strokes primary events growing decade vascular patients evidence foresee efficacy importance reduce through treatment antithrombotic aspects review therapy medical changes lifestyle combination including strategies optimal emerged during Approximately figures
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms